These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2654660)

  • 21. Transperitoneal movement and pharmacokinetics of cefotiam and cefsulodin in patients on continuous ambulatory peritoneal dialysis.
    Brouard R; Tozer TN; Merdjan H; Guillemin A; Baumelou A
    Clin Nephrol; 1988 Oct; 30(4):197-206. PubMed ID: 3214965
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum and dialyzate concentrations of intraperitoneal cephalothin in patients undergoing continuous ambulatory peritoneal dialysis.
    Münch R; Steurer J; Lüthy R; Siegenthaler W; Kuhlmann U
    Clin Nephrol; 1983 Jul; 20(1):40-3. PubMed ID: 6883818
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of phosphatidylcholine on peritoneal transport and lymphatic absorption in a CAPD patient with sclerosing peritonitis.
    Struijk DG; van der Reijden HJ; Krediet RT; Koomen GC; Arisz L
    Nephron; 1989; 51(4):577-8. PubMed ID: 2739844
    [No Abstract]   [Full Text] [Related]  

  • 24. Peritonitis in children undergoing continuous ambulatory peritoneal dialysis.
    Fine RN; Salusky IB; Hall T; Lucullo L; Jordan SC; Ettenger RB
    Pediatrics; 1983 May; 71(5):806-9. PubMed ID: 6835766
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The long-term effects of single peritonitis episodes on peritoneal equilibration test results in continuous ambulatory peritoneal dialysis patients.
    Hung SY; Chung HM
    Adv Perit Dial; 2001; 17():196-9. PubMed ID: 11510273
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical aspects of peritoneal permeability.
    Krediet RT; Berkinshaw K; Boeschoten EW; Arisz L
    Neth J Med; 1985; 28(10):424-34. PubMed ID: 3908951
    [No Abstract]   [Full Text] [Related]  

  • 27. [Replacement of the peritoneal dialysis catheter in persistent peritonitis in continuous ambulatory peritoneal dialysis].
    Marichal JF; Faller B; Mengus C; Wagner JD; Frey G
    Nephrologie; 1985; 6(1):7-10. PubMed ID: 4000380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluating peritoneal fluid transport in continuous peritoneal dialysis patients: a practical approach.
    Zhe XW; Tian XK; Shan YS; Cheng L; Wang T
    Nephron Clin Pract; 2007; 107(4):c123-7. PubMed ID: 17957122
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Defining peritoneal dialysis adequacy: Kt/Vurea revisited.
    Zhe XW; Shan YS; Cheng L; Tian XK; Wang T
    Ren Fail; 2007; 29(3):347-52. PubMed ID: 17497450
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Physiological approaches to increase biocompatibility of peritoneal dialysis.
    Breborowicz A; Oreopoulos DG
    Perit Dial Int; 1995; 15(7 Suppl):S76-85; discussion S85-6. PubMed ID: 8555331
    [No Abstract]   [Full Text] [Related]  

  • 31. Contribution of lymphatic absorption to loss of ultrafiltration and solute clearances in continuous ambulatory peritoneal dialysis.
    Mactier RA; Khanna R; Twardowski Z; Moore H; Nolph KD
    J Clin Invest; 1987 Nov; 80(5):1311-6. PubMed ID: 3680499
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discrepancy between solute transport rate and drain volume in CAPD patients with ascites.
    Yoon SN; Yang CW; Lee SH; Kim YS; Choi EJ; Chang YS; Bang BK
    Adv Perit Dial; 1996; 12():39-42. PubMed ID: 8865869
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lymphatic removal of dialysate from the peritoneal cavity of anesthetized sheep.
    Abernethy NJ; Chin W; Hay JB; Rodela H; Oreopoulos D; Johnston MG
    Kidney Int; 1991 Aug; 40(2):174-81. PubMed ID: 1942765
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of diaphragmatic, visceral, and parietal pathways in peritoneal fluid absorption in rat peritoneal dialysis.
    Kumano K; Go K; He M; Sakai T
    Perit Dial Int; 1996; 16 Suppl 1():S80-3. PubMed ID: 8728168
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Withdrawal of continuous ambulatory peritoneal dialysis to treat mild peritonitis.
    Pagniez DC; MacNamara E; Fortin F; Delvallez L; Fruchart A; Dequiedt P; Tacquet A
    BMJ; 1988 Nov; 297(6657):1174-5. PubMed ID: 3144336
    [No Abstract]   [Full Text] [Related]  

  • 36. Induction of peritoneal-fluid eosinophilia by intraperitoneal air in patients on continuous ambulatory peritoneal dialysis.
    Daugirdas JT; Leehey DJ; Popli S; Gandhi VC; Zayas I; Hoffman W; Ing TS
    N Engl J Med; 1985 Dec; 313(23):1481. PubMed ID: 4058558
    [No Abstract]   [Full Text] [Related]  

  • 37. Pathogenesis of peritoneal fibrosis and peritoneal small vessel changes.
    Nakamoto M
    Perit Dial Int; 1996; 16 Suppl 1():S39-41. PubMed ID: 8728160
    [No Abstract]   [Full Text] [Related]  

  • 38. Impact of surface area and permeability on solute clearances.
    Krediet RT; Zemel D; Imholz AL; Struijk DG
    Perit Dial Int; 1994; 14 Suppl 3():S70-7. PubMed ID: 7948281
    [No Abstract]   [Full Text] [Related]  

  • 39. The necessity of adjusting dialysate volume to body surface area in pediatric peritoneal equilibration tests.
    de Boer AW; van Schaijk TC; Willems HL; Reddingius RE; Monnens LA; Schröder CH
    Perit Dial Int; 1997; 17(2):199-202. PubMed ID: 9159845
    [No Abstract]   [Full Text] [Related]  

  • 40. Osmotic agents in the peritoneal fluid.
    Veys N; Ringoir S; Lameire N
    Contrib Nephrol; 1990; 84():27-35. PubMed ID: 2261779
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.